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g-Secretase is an intramembrane protease complex that mediates the Notch signaling pathway and the
production of amyloid b-proteins. As such, this enzyme has emerged as an important target for development
of novel therapeutics for Alzheimer disease and cancer. Great progress has been made in the identification
and characterization of the membrane complex and its biological functions. One major challenge now is to
illuminate the structure of this fascinating and important protease at atomic resolution. Here, we review
recent progress on biochemical and biophysical probing of the structure of the four-component complex
and discuss obstacles and potential pathways toward elucidating its detailed structure.Introduction: g-Secretase and Alzheimer Disease
Alzheimer disease (AD) is a highly prevalent neurodegenerative
disorder defined by the presence of abundant proteinaceous
deposits—extraneuronal amyloid plaques and intraneuronal
neurofibrillary tangles—in limbic and cortical regions of the
human brain (St. George-Hyslop, 2000). An amyloid plaque is
a fibrous aggregate composed principally of amyloid b-proteins
(Ab) of 39–43 amino acids, whereas a neurofibrillary tangle is
mainly composed of aggregated, hyperphosphorylated tau, a
cytosolic protein that is normally associated with microtubules.
The causes of the common, late-onset form of AD are largely
unknown, and the molecular pathway between extracellular Ab
accumulation and the development of the intraneuronal tangles
is poorly understood. Certain autosomal dominant genetic alter-
ations can predispose people to the disease, but many individ-
uals without a known genetic predisposition develop AD in their
60s and beyond. The Ab cascade hypothesis postulates that in
both autosomal dominant forms that have accelerated rates of
Ab production and apparently ‘‘sporadic’’ forms that accumulate
Ab later in life, an initial elevation of soluble Ab monomers and
then oligomers and their subsequent aggregation and deposition
into amyloid fibrils leads gradually to widespread synaptic,
neuronal, and glial dysfunction accompanied by declining
memory and ultimately a multifaceted, profound dementia
(Hardy and Selkoe, 2002; Shankar et al., 2008).
Ab is a proteolytic product of amyloid b-protein precursor
(APP), a large (770 amino acids maximum) type 1 transmem-
brane glycoprotein widely expressed in mammals (Figure 1)
(Hardy and Selkoe, 2002). The physiological activities of the
precursor are partially understood, and APP has been implicated
in cell adhesion, cell signaling, and protease inhibition and devel-
opment (Wolfe and Guenette, 2007). The large extracellular
region of APP has an extracellular subdomain E1, containing
a copper-binding motif (Barnham et al., 2003), an alternatively
spliced Kunitz-type protease inhibitor domain (Tanzi et al.,
1988), and an extracellular subdomain E2 composed of two
connected coiled coils (Wang and Ha, 2004). The single trans-
membrane domain (TMD) of APP is located near the carboxyl326 Structure 17, March 11, 2009 ª2009 Elsevier Ltd All rights reservend, and the Ab peptides originate in part from this domain.
There is evidence that the APP TMD can dimerize (Beel et al.,
2008; Gorman et al., 2008), and mutations of the glycine residues
in the GxxxG motif attenuate the TMD dimerization strength and
reduce production of Ab42 (Munter et al., 2007). APP undergoes
ectodomain shedding in which its large, receptor-like N-terminal
region is cleaved off, either by a-secretase at position Lys687
(APP770 numbering) to generate an 83-residue membrane-
retained stub or by b-secretase at position Asp672 to generate
a 99-residue membrane stub. Both C83 and C99 are substrates
for a third membrane-associated protease called g-secretase.
The Ab peptides are produced from C99; the cleavage products
from C83 by g-secretase are N-terminally truncated forms of Ab
referred to as p3. Peptide hydrolysis mediated by g-secretase is
unusual because the cleavage occurs within the hydrophobic
lipid bilayer.
g-Secretase belongs to a diverse family of intramembrane-
cleaving proteases (I-CLiPs) (Wolfe and Kopan, 2004). g-Secre-
tase is now known to be composed of four integral membrane
proteins: presenilin, nicastrin, Aph-1, and Pen-2 (Edbauer
et al., 2003; Kimberly et al., 2003; Takasugi et al., 2003), with
presenilin being an aspartyl protease that is the catalytic subunit
(De Strooper et al., 1998; Wolfe et al., 1999). The identification of
these proteins was a result of convergent efforts along two
initially unrelated lines of research (Selkoe and Wolfe, 2007): in
the pathobiology, searching for the enigmatic g-secretase that
generates Ab, and in developmental biology, searching for
components of the Notch signaling pathway. The four subunits
are now known to be both necessary and sufficient for active
g-secretase. However, there are other factors, for example,
TMP21 and CD147, that have been reported to modulate g-sec-
retase activity (Chen et al., 2006; Zhou et al., 2005). Numerous
mutations have been identified in both the proteolytic compo-
nent, presenilin, and the substrate, APP, that influence the
production of Ab peptides (Goate et al., 1991; Hardy and Selkoe,
2002; Scheuner et al., 1996). The g-secretase complex also
functions in many other cellular processes. Perhaps the most
well-studied to date is the Notch signaling pathway, whiched
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specification. In this role, g-secretase releases the Notch intra-
cellular fragment that subsequently enters the nucleus and regu-
lates transcriptional programs (De Strooper et al., 1999; Struhl
and Greenwald, 1999).
The necessary role of g-secretase in the pathogenesis of AD
commends it as a major target for drug development. But its
multiple roles in many essential cellular functions complicate
its chronic inhibition to treat or prevent AD. It is currently believed
that it will be possible to develop g-secretase inhibitors or modu-
lators that alter Ab-generating activity while preserving other
essential biological functions of the protease (Wolfe, 2008).
g-Secretase is also a target for developing anticancer agents
(Shih and Wang, 2007). A high-resolution structure would be
invaluable in understanding the biology of the g-secretase
complex and in facilitating inhibitor design.
Presenilin as the Catalytic Subunit
of the g-Secretase Complex
Human presenilin 1 is a 467-residue, 50 kDa transmembrane
protein. Its homolog, presenilin 2, is four amino acids shorter,
missing residues 26–29 near the amino terminus. There is a
consensus now, after some controversy, that presenilin has
a nine-TMD topology, with a cytosolic amino terminus and
a lumenal carboxyl terminus (Figure 2A) (Henricson et al., 2005;
Laudon et al., 2005; Spasic et al., 2006). In the active g-secretase
complex, presenilin is cleaved between residues N292 and V293
into an amino terminal fragment (NTF) (30 kDa, TMD1-6) and
a carboxyl terminal fragment (CTF) (20 kDa, TMD 7-9). This en-
doproteolysis appears to be an intramolecular autocatalytic
event (Brunkan et al., 2005; Wolfe et al., 1999) that is carried
out by the same g-secretase activity that cleaves other
substrates. Such a notion arose from the observation that the
presenilin active site mutants D257A or D385A do not undergo
endoproteolysis and cannot cleave substrates (Wolfe et al.,
1999). The endoproteolysis of presenilin (or the omission of
exon 9 as an exceedingly rare familial AD mutation) apparently re-
moves steric hindrance of the large cytoplasmic loop between
TMDs 6 and 7, thus enabling presenilin to take on its enzymati-
Figure 1. Stepwise Proteolytic Processing
of APP by a-, b-, and g-Secretases
Major cleavage sites of the three secretases in
APP are indicated by dashed horizontal lines.
The TMD is depicted as a cylinder. The Ab-domain
is depicted in orange, and the AICD in green.
Figure is not drawn to scale. Ab represents
amyloid b peptide; AICD, APP intracellular
domain; APP, amyloid precursor protein; C83,
83-residue APP C-terminal fragment; C99, 99-
residue APP C-terminal fragment. See text for
details.
cally active conformation. The NTF and
CTF remain bound together after the
cleavage (Thinakaran et al., 1996).
Regarding the intramolecular arrange-
ment of the TMDs in presenilin, it is known
that TMD6 and TMD7, each harboring
a catalytic aspartic acid at D257 and
D385, are clustered at the active site (Sato et al., 2006; Tolia
et al., 2006). In addition, TMD1 has been shown by disulfide
crosslinking to be near TMD8 (Kornilova et al., 2006). TMD9
also appears to be near the catalytic pore and might be involved
in the initial binding of substrates (Tolia et al., 2008). Substituted
cysteine accessibility experiments have demonstrated a hydro-
philic pore within the membrane at the active site formed by
TMD6 and TMD7 (Sato et al., 2006; Tolia et al., 2006).
Only a fraction of cellular presenilin actually forms the g-secre-
tase complex (Lai et al., 2003). It is postulated that presenilin
might have functions outside the g-secretase complex. For
examples, presenilin has been reported to function as a low-
conductance Ca2+ leak channel (Tu et al., 2006) and might
thus be involved in neuronal Ca2+ signaling and homeostasis
(Smith et al., 2005). Presenilin also interacts with and, as a conse-
quence, stabilizes b-catenin (Serban et al., 2005; Zhang et al.,
1998). Because b-catenin upregulates the expression of several
genes associated with cancers in adults (Moon et al., 2002), pre-
senilin mutations might play a role in causing certain cancers.
Assembly of g-Secretase Is a Stepwise Process
In addition to presenilin, the other three components in g-secre-
tase complex are Aph-1, nicastrin, and Pen-2 (Figure 2A). Aph-1
has a topology of seven TMD with a cytosolic carboxyl terminus
(Fortna et al., 2004). Pen-2 is a 2-TMD hairpin-like protein with
both ends in the lumen (Crystal et al., 2003). Nicastrin is a type 1
membrane glycoprotein with a large lumenal domain. The ectodo-
mainof nicastrin sharesa common foldwith the peptidases (Fagan
etal., 2001).The ectodomain is involved in the assemblyand matu-
rationof the complex (Chavez-Gutierrezetal., 2008) and itsconfor-
mational change upon activation of the g-secretase complex
(Shirotani et al., 2003). There are up to 16 potential N-glycosylation
sites, although glycosylation doesn’t appear to be necessary for
the function of g-secretase (Herreman et al., 2003).
g-Secretase appears to follow a defined and stepwise
assembly pathway. Initially, nicastrin and Aph-1 form a binary
subcomplex (Shirotani et al., 2004), and this half-complex is
stable in the detergent n-dodecyl-b-D-maltopyranoside, which
dissolves the four-member complex (Fraering et al., 2004a).Structure 17, March 11, 2009 ª2009 Elsevier Ltd All rights reserved 327
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plex to form a heterotrimeric subcomplex (Takasugi et al.,
2003). Finally, Pen-2 joins the trimeric subcomplex, resulting in
the formation and activation of the mature g-secretase complex
(LaVoie et al., 2003; Niimura et al., 2005). The addition of Pen-2
might allow the endoproteolysis of presenilin to occur, thereby
activating the protease. The g-secretase complex might have
already fully assembled in ER, but there is some evidence that
its full activation might occur in a slightly acidic export compart-
ment downstream of the ER (Kim et al., 2007).
g-Secretase Is a Monomeric Complex with a 1:1:1:1
Stoichiometry of Its Four Components
There has been some controversy concerning the stoichiometry
of the g-secretase complex, both in terms of the overall oligo-
merization state and the copy number of individual subunits,
particularly presenilin. For example, the dimerization of preseni-
lin at the catalytic core has been suggested (Hebert et al., 2003;
Schroeter et al., 2003). The calculated molecular weight based
on protein sequence, assuming one copy each of the four
subunits, is about 200 kDa. Purified g-secretase runs on some
Blue Native gels at around 500 kDa, implying that g-secretase
might be a dimeric complex. However, molecular sizing based
on electrophoresis can be unreliable, particularly in the case of
membrane protein complexes, because of different migration
characteristics of these hydrophobic proteins with respect to
water-soluble molecular weight markers (Osenkowski et al.,
2009). Glycosylation of nicastrin adds another layer of uncer-
tainty, because the strongly charged sialic acid might bind
disproportionally to the dye molecule, increasing the apparent
weight of the complex in gels.
A
B
Figure 2. The Architecture of the
g-Secretase Complex
(A) Subunit topology.
(B) Putative subunit arrangement in the g-secre-
tase complex, as modeled after Steiner et al.
(2008). Numbers denote the predicted molecular
weights of the component proteins. D denotes
the two catalytic aspartates in presenilin. See
text for details.
Recent work with purified and function-
ally active complexes revealed a 1:1:1:1
stoichiometry of the four g-components
(Sato et al., 2007). Consistent with this
stoichiometry, the absolute mass of the
purified g-secretase as measured by
scanning transmission electron micros-
copy (EM) is 230 kDa (Osenkowski
et al., 2009). The extra 30 kDa above
the theoretical mass may be accounted
for by the glycosylation state of nicastrin.
Therefore, it is likely based on the latest
evidence thatg-secretase is a monomeric
complex with one copy each of its four
components, although the data cannot
role out the possibility of the presence
of an extra Pen-2 subunit. We also note
that this stoichiometry is established for
the detergent purified g-secretase complex from the overex-
pressing system, in which every g-component has one or more
exogenous tags. Therefore, it remains to be seen if this conclu-
sion can be applied to the endogenous complexes in vivo.
However, oligomerization, even if it can occur under some condi-
tions, is unlikely to play a significant role in g-secretase activity,
because purified monomeric g-secretase complex is fully
functional (Cacquevel et al., 2008; Fraering et al., 2004b).
The Architecture of g-Secretase Complex
Figure 2B summarizes the overall architecture of g-secretase
complex, based on pairwise interactions, partial complexes in
different types and concentrations of detergents (Fraering et al.,
2004a), and chemical crosslinking (Sato et al., 2006; Schroeter
et al., 2003; Steiner et al., 2008; Thinakaran et al., 1998). First,
there is a tight interaction between nicastrin and Aph-1. The
NTF and the CTF of presenilin further interact with Pen-2 and
nicastrin, respectively. There are two mammalian isoforms of
presenilin (PS1 and PS2) and three of Aph-1 (Aph1a-short,
Aph1a-long, and Aph-1b), resulting in six possible g-secretase
complexes (Shirotani et al., 2007; Wakabayashi and De Strooper,
2008). Despite their potential differences in specific activities
(Serneels et al., 2005), the architecture of these g-secretases
appears to be essentially the same (Steiner et al., 2008).
g-Secretase is the only intramembrane protease to date that
functions as a multisubunit protein complex; other I-CLiPs are
single-protein enzymes. The obvious question is: what are the
roles for each component and why are there so many compo-
nents in g-secretase? Whereas presenilin has been shown to
function as the catalytic subunit, the exact roles of the other three
subunits are not clearly defined, beyond that they are necessary328 Structure 17, March 11, 2009 ª2009 Elsevier Ltd All rights reserved
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multiple components might be that g-secretase acquired over
evolution the ability to cleave peptide bond rather nonspecifi-
cally, so that there is a need to effectively sequester the active
site using other protein partners, in order to prevent unintended
proteolysis. More subunits might also afford fine-tuning the
activity of g-secretase in response to its environmental cues.
Substrate Specificity or Nonspecificity of g-Secretase
In addition to APP and Notch, g-secretase processes more than
80 other transmembrane protein substrates (Beel and Sanders,
2008; Hemming et al., 2008; Wakabayashi and De Strooper,
2008). No consensus sequence motif can be recognized among
these substrates. So are there general characteristics that make
a protein a g-secretase substrate? The answer seems to be yes.
The general requirements are: (1) a type 1 transmembrane helix;
(2) a small ectodomain, usually resulting from prior shedding by
an a-secretase-like protease; (3) permissive determinants in the
juxtamembrane and cytoplasmic domains (Hemming et al.,
2008); and perhaps (4) residues that can destabilize the helical
configuration of the TMD around the cleavage site (Beel and
Sanders, 2008). Because both g-secretase and its substrates
reside in the confined 2D space of the lipid bilayer, it was previ-
ously hypothesized that g-secretase might have little or no
sequence specificity and cleave virtually any hydrophobic
a-helical domain. In this sense, g-secretase might be considered
as a membrane equivalent of the cytoplasmic proteasome
(Kopan and Ilagan, 2004; Small, 2002). However, recent studies
suggest that there are specific determinants that make a poly-
peptide a substrate of g-secretase and other presenilin-like
intramembrane proteases (Hemming et al., 2008; Martin et al.,
2008; Ren et al., 2007). Nevertheless, there are certain parallels
between g-secretase and the proteasome: (1) both undergo
a defined assembly process; (2) both require a maturation step
before becoming enzymatically active: in the proteasome, the
propeptide is auto-cleaved as the final maturation step, and in
g-secretase, the large cytoplasmic loop between TMD6 and
TMD7 in presenilin is also auto-cleaved to activate the complex.
Proteasomal substrates are tagged with a ubiquitin chain and
translocated in an ATP-dependant manner through an entrance
for proteolysis. In analogy to the proteasome, one might ask, if
there is a defined gating mechanism, a subunit that acts in
substrate recognition and/or translocation, or a tagging system
that marks substrates for g-secretase cleavage? It will be inter-
esting to see whether certain domains of the four-member
complex or one of the postulated the g-secretase modulatory
proteins play such roles. Again, elucidating the structure of
g-secretase should help us understand some of these questions.
The Cryo-EM Structure of g-Secretase Complex
The structure of recombinant human g-secretase complex
expressed in CHO cells was initially studied by negative stain
EM and 3D image reconstruction (Lazarov et al., 2006). g-Secre-
tase was found to have a spherical structure about 8–10 nm in
diameter with a low-density interior (2 nm) that was suggested
to be a water-accessible proteolytic chamber. However, another
study using a g-secretase preparation from Sf9 cells produced
a much larger, Y-shaped structure at 30–50 nm in size with an
unusually large central pore (>10 nm) (Ogura et al., 2006).StrucAlthough the exact reason for this discrepancy is unclear, we
suspect that differences in the g-secretase constructs might
be responsible. In our g-30 CHO cell line, there was no His-tag
on any of the four components (Lazarov et al., 2006). In the Sf9
expression system, three of the four protein components (prese-
nilin-1, nicastrin, and Aph-1) contained a His-tag (Ogura et al.,
2006). The 6XHis-tag is positively charged and is capable of
altering the oligomeric state of membrane proteins (Amor-Mah-
joub et al., 2006; Li et al., 2004; Wu and Filutowicz, 1999).
Thus, it is possible that the three His-tags in each g-secretase
might have induced artificial oligomerization of the Sf9-purified
g-secretase complex, potentially explaining the unusually large
observed size (Ogura et al., 2006).
Recently, an improved structure of g-secretase was deter-
mined by cryo-EM at a nominal resolution of 12 A˚ (Osenkowski
et al., 2009). Cryo-EM reveals a protein structure itself, rather
than a surface envelope of the protein structure as contoured
by heavy metal stain, which is the case in the negative stain
method. Therefore, the cryo-EM method provides a potentially
more reliable structure by circumventing several shortcomings
in negative stain EM, such as uneven staining, stain-induced
flattening, and possible stain penetration to the interior of
a protein structure. The cryo-EM structure was determined
from a new human g-secretase preparation (purified from our
S20 CHO cell line) that contained a 6XHis-tag at the carboxyl
terminus of nicastrin (Cacquevel et al., 2008). It was verified
that this single His-tag did not cause oligomerization of
the g-secretase complex. The overall size and shape of the
S20 g-secretase was essentially the same as the g30 cell-
derived g-secretase that had no 6XHis-tag (Lazarov et al.,
2006). The new cryo-EM structure reveals three smaller low-
density interior regions; these regions do not coalesce to form
a single chamber as observed in the negative stain structure
(Lazarov et al., 2006). The cryo-EM structure has better defini-
tion than the previous stained structure in that the 4 nm thick
transmembrane region and four extracellular density domains
are resolved (Osenkowski et al., 2009) (Figure 3).
g-Secretase is one of the four families of intramembrane
proteases. Because the crystal structures of two intramembrane
proteases, the serine protease rhomboid and the metallopro-
tease S2P, were solved recently (Figure 3) (Ben-Shem et al.,
2007; Feng et al., 2007; Lemieux et al., 2007; Wang et al.,
2006; Wu et al., 2006), we asked whether these structures
resemble the g-secretase. Unfortunately, these six-TMD
single-polypeptide proteases share no sequence or structural
similarity among themselves or with g-secretase (Urban and
Shi, 2008). However, all reside in similar hydrophobic bilayer
environments and perform virtually the same task of hydrolyzing
peptide bonds; thus, the intramembrane proteases all face the
same requirements of admitting the transmembrane helical
substrates as well as water molecules into their respective cata-
lytic sites located within the bilayer. Therefore, a side-by-side
comparison of the structures of these proteases might still be
meaningful (Figure 3). Indeed, there appears to be a vertically
oriented groove on the surface in the transmembrane portion
of each of these structures (Figure 3A). These grooves likely
represent the initial substrate docking sites (Kornilova et al.,
2005). Binding of a substrate to the docking site on an intramem-
brane protease should induce a lateral gate opening in theture 17, March 11, 2009 ª2009 Elsevier Ltd All rights reserved 329
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switch at the cleavage site in the substrate structure (Beel and
Sanders, 2008), such that the substrate could enter into the
catalytic site and be ready for processing. The vertical sections
of these structures show sizable cavities that open to the cyto-
plasm and/or extracellular regions, indicating that water has
access to the interior of the enzymes where the catalytic sites
reside, even in the absence of their respective substrates
(Figure 3B). Thus, the intramembrane proteases appear to
have solved the conundrum of hydrolyzing peptide bonds in
a hydrophobic environment by simply creating a hydrophilic,
water-accessible cavity in the greasy membrane (Urban and
Shi, 2008). In all three cases, the water pathway appears to reach
as far as the catalytic site – but does not cross the membrane.
This might be important to preserve membrane potentials (Ha,
2007; Urban and Shi, 2008).
Barriers and Possible Pathways to the Structural
Solution of the g-Secretase Complex
The low-resolution cryo-EM map of g-secretase has whetted our
appetite for a higher resolution structure. However, a crystal
structure of the full g-complex might not be on the horizon just
yet. The complex maturation pathway (Spasic and Annaert,
2008), the general requirement of certain lipids for activity (Osen-
kowski et al., 2008), the multiple glycosylations of nicastrin, the
tendency to break into subcomplexes in detergents that are
more appropriate for structural studies (Fraering et al., 2004a),
the existence of multiple isoforms of Aph-1 and presenilin re-
sulting in at least six different g-complexes (Wakabayashi and
De Strooper, 2008), and the relatively small quantity of the
g-complex that can be produced for crystallization trials (Cacque-
vel et al., 2008) are all formidable barriers to achieving the crystal
structure of this 19-TMD complex. However, much progress has
been made in recent years in overexpressing mammalian
membrane proteins (Tate, 2001), in robot-based nanocrystallog-
raphy that significantly reduces the required amount of highly
purified specimen (Bodenstaff et al., 2002), and in the availability
of synchrotron-based X-ray diffraction equipment enabling the
A
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Figure 3. A 12 A˚ Resolution Structure of g-Secretase by Cryo-
Electron Microscopy in Comparison with the Crystal
Structures of Certain Bacterial and Archaeal Intramembrane
Proteases
(A) Surface-rendered side view of g-secretase structure (left), and
space-filling models of the GlpG serine protease crystal structure
(middle) (Protein Data Bank [PDB] ID 2NRF) and the S2P Zn protease
(right) (PDB ID 3B4R). A thick red curve indicates an apparent
membrane surface groove that is hypothesized to represent the
approximate position at which an a-helical substrate might bind.
(B) Vertically cut-open views of the three structures shown in (A). The
dashed red lines indicate the potential water-accessible spaces. The
active sites in GlpG and S2P are indicated by white asterisks. The loca-
tion of the active site within g-secretase is currently unknown.
use of ever-smaller crystals (Jiang and Sweet, 2004).
Considering how seemingly impossible an atomic struc-
ture of an ion channel or a transporter was 20 years ago
and how many such crystal structures are available now
(Gouaux and Mackinnon, 2005), it might be reasonable to
expect that the atomic structure of g-secretase will be
achieved in the not-so-distant future.
Besides attempting crystallization of the entire g-complex,
another route for the X-ray crystallography approach would be
to solve the structures of individual components or domains of
complex. In this regard, signal peptide peptidase, a homolog
of presenilin (Narayanan et al., 2007), the nicastrin ectodomain
(Shah et al., 2005), Aph1, and PEN-2 might each be a good target
for crystallography or nuclear magnetic resonance structure
determination. The presenilin holoprotein has been efficiently ex-
pressed alone in Sf9 insect cells and purified from microsomes
(Tu et al., 2006). This provides a unique opportunity for solving
the structure of the catalytic subunit of g-secretase. When the
high-resolution structures of these g-secretase components
become available, interpretation of the lower resolution EM
structure of the intact g-complex will be more meaningful.
In recent years, the methodology of single particle cryo-EM
has advanced dramatically, to a point that near-atomic resolu-
tion structures for a number of very large and highly symmetrical
biological assemblies such as the icosahedral or helical virus
have been achieved (Jiang et al., 2008; Yu et al., 2008; Zhang
et al., 2008). The attainable resolution for several very large
protein complexes without any symmetry has also been signifi-
cantly advanced to well within the nanometer resolution range
(Agirrezabala et al., 2008; Chandramouli et al., 2008; Matadeen
et al., 1999). It might thus be possible for the atomic resolution
cryo-EM structure of a very large asymmetrical complex to be
achieved. However, large and tightly packed protein complexes
with masses well over 1 MDa are a minority in biology. The vast
majority of the known protein complexes are in the size range of
100–400 kDa, a range to which g-secretase belongs. From
a structural biologist’s point of view, it is a difficult middle ground,
because this range is somewhat too big for X-ray crystallography
and too small for single particle cryo-EM.
Cryo-EM likely will continue to play an important role in our
understanding of the structure and function of the g-secretase
complex. In the absence of atomic structure of the g-secretase
by crystallography, more work by cryo-EM might further improve
the resolution of the existing structure of the g-secretase
complex; it might be possible to determine the EM structure at330 Structure 17, March 11, 2009 ª2009 Elsevier Ltd All rights reserved
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far more desirable or informative than the 12 A˚ structure we have
obtained, because many of the predicted transmembrane helices
would be resolved, so that homology-based modeling or docking
of the component atomic structures, once available, into the
EM structure could be carried out. Furthermore, the potential
substrate docking site and the catalytic site could also be visual-
ized by determining the cryo-EM structures of a catalytically inac-
tive (aspartate mutant) g-secretase in complex with substrates or
helical peptide inhibitors (Bihel et al., 2004). When an atomic
structure is finally achieved by X-ray crystallography, the EM
structure may serve to cross-validate the physiological relevance
of crystal structures that could be influenced by the crystalline
packing. An interesting case in point is the role cryo-EM played
in supporting the protein-lipid interface movement model of the
voltage sensor paddle as proposed from the crystal structures
of potassium channels (Jiang et al., 2004).
Within the cryo-EM single particle approach, despite its theo-
retical potential for determining relatively small protein structures
down to 40 kDa (Henderson, 1995), several practical issues,
including beam-induced specimen charging and specimen
movement, have so far hindered its realization. Another problem
in single particle cryo-EM is the reliance on phase contrast
generated by deeply underfocusing the objective lens. A large
defocus value not only scrambles the higher frequency informa-
tion in the micrographs that makes accurate information
recovery difficult but also significantly cuts off the very low
frequency information that is essential for image alignment.
The emerging technique of phase plate enables in-focus electron
imaging while still providing high image contrast (Cambie et al.,
2007; Danev and Nagayama, 2001). This technique will likely
make a significant difference in cryo-EM structural determination
of relatively small protein complexes such as g-secretase.
The cryo-EM method also encompasses another approach
that is called electron crystallography (Fujiyoshi and Unwin,
2008). With this approach, detergent-purified membrane
proteins are reconstituted back into a lipid bilayer, forming 2D
crystalline sheets. The structures then are determined by extract-
ing the amplitudes from electron diffraction patterns and the
phases from high-resolution electron images of these crystalline
sheets (Glaeser et al., 2007). Membrane protein structures solved
by this method are invaluable in evaluating the X-ray crystal str-
uctures that are necessarily solved in detergents (Fujiyoshi and
Unwin, 2008). For g-secretase, the lipid environment appears to
be particularly important, because its proteolytic function occurs
within the lipid bilayer, and this function is regulated by the lipid
composition (Osenkowski et al., 2008). Many 2D crystals of
membrane proteins reported so far do not diffract to a high reso-
lution; nevertheless, there are several examples where atomic
resolution structures have been solved by electron crystallog-
raphy (Fujiyoshi and Unwin, 2008; Gonen et al., 2005). Therefore,
we hope that electron crystallography will also contribute to the
structural assault on the g-secretase complex.
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